Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Irinotecan and Cisplatin for Locally Advanced Gastric Cancer
NCT00062374Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2003
- Primary completion
- Jun 2011
- Modality
- Nanoparticles, Monoclonal Antibodies, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumab in gastric cancer (GC), sponsored by National Cancer Institute. Started Jun 2003; status: completed.
02
Drugs
irinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumab
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00062374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00062374.